Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Eclipse retinopathy


Purpose Solar retinopathy is a well-recognised clinical entity of macular damage caused by viewing the sun, induced by a photochemical process. The term ‘eclipse retinopathy’ is frequently employed when the condition is sustained as a result of viewing a solar eclipse. Considerable public excitement had been raised in anticipation of the full solar eclipse on 11 August 1999. Whilst experience has shown that visual morbidity is likely to be temporary, current evidence is anecdotal and restricted to isolated case reports and series. This study was conducted to establish the true visual morbidity associated with a solar eclipse, and whether it was temporary or permanent.

Methods A 3 month active case ascertainment study was carried out from July to September 1999 to record cases presenting to ophthalmologists with visual symptoms arising from solar viewing. Further information about the cases was sought using a short questionnaire. A follow-up questionnaire requesting outcome data at 6 months was also employed.

Results There were 70 reported cases of visual loss. The average age was 29.5 ± 12.9 years. Half the cases presented to an ophthalmologist within 2 days of the eclipse. An abnormal macular appearance was reported in 84% of patients at presentation. There have been no reported cases of continued visual loss or symptoms at 6 months.

Conclusions This is the largest nationwide study of the visual effects of a solar eclipse ever undertaken. There were no recorded cases of permanent visual loss, which corroborates the previous evidence that visual morbidity is likely to be temporary. It would appear probable that public health education was most effective in reducing visual morbidity and hence keeping the consequent burden on the NHS to a minimum.


  1. 1

    Penner R, McNair JN . Eclipse blindness. Am J Ophthalmol 1966;61:1452–7.

    CAS  Article  Google Scholar 

  2. 2

    MacFaul PA . Visual prognosis after solar retinopathy. Br J Ophthalmol 1969;53:534–41.

    CAS  Article  Google Scholar 

  3. 3

    Ridgeway AEA . Solar retinopathy. BMJ 1967;III:212–4.

    Article  Google Scholar 

  4. 4

    Rosen E . Solar retinitis. Br J Ophthalmol 1948;32:23–34.

    CAS  Article  Google Scholar 

  5. 5

    Anaclerio M, Wicker HS . Self-induced solar retinopathy by patients in a psychiatric hospital. Am J Ophthalmol 1970;69:731–6.

    CAS  Article  Google Scholar 

  6. 6

    Ewald RA, Ritchey CL . Sungazing as the cause of foveomacular retinitis. Am J Ophthalmol 1970;70:491–7.

    Article  Google Scholar 

  7. 7

    Bates WH . The cure of imperfect sight by treatment without glasses. (Solar retinopathy in Manchester area.) Trans Ophthalmol Soc 1920;104:625–8.

    Google Scholar 

  8. 8

    Duke-Elder S . System of ophthalmology. Vol 4. Non-mechanical injuries. St Louis: CV Mosby, 1972:837–916.

  9. 9

    Gass JD . Stereoscopic atlas of macular disease. St Louis: CV Mosby, 1977:322–6.

  10. 10

    Yannuzi LA, Gitter S, Schatz H . The macula: a comprehensive text and atlas. Baltimore: Williams and Wilkins, 1980:331.

  11. 11

    Irvine SR . A review of solar retinitis as it may pertain to macular lesions seen in personnel of the Armed Forces. Am J Ophthalmol 1945;28:1158–65.

    Article  Google Scholar 

  12. 12

    Kerr LM, Little HL . Foveomacular retinitis. Arch Ophthalmol 1966;76:498–504.

    CAS  Article  Google Scholar 

  13. 13

    Wergeland FL, Brenner EH . Solar retinopathy and foveomacular retinitis. Ann Ophthalmol 1975;7:495–503.

    PubMed  Google Scholar 

  14. 14

    Hope-Ross MW, Mahon GJ, Gardiner TA, Archer DB . Ultrastructural findings in solar retinopathy. Eye 1993;7:29–33.

    Article  Google Scholar 

  15. 15

    Yanuzzi LA, Fisher YL, Krueger A, Slakter J . Solar retinopathy: a photobiological and geophysical analysis. Trans Am Ophthalmol Soc 1987;85:120–58.

    Google Scholar 

  16. 16

    Atmaca LS, Idil A, Can D . Early and late visual prognosis in solar retinopathy. Graefes Arch Clin Exp Ophthalmol 1995;233:801–4.

    CAS  Article  Google Scholar 

  17. 17

    Rosner M, Lam TT, Tso MO . Therapeutic parameters of methylprednisolone treatment for retinal photic injury in a rat model. Res Commun Chem Pathol Pharmacol 1992;77:299–311.

    CAS  PubMed  Google Scholar 

  18. 18

    Chou BR . Retinal protection from solar photic injury. Am J Optom Phys Optics 1981;58:570–80.

    Article  Google Scholar 

  19. 19

    Sliney DH, Wolbarsht ML . Safety with lasers and other optical sources. New York: Plenum Press, 1980.

  20. 20

    Marsh JCD . Observing the sun in safety. J Br Astron Assoc 1982;92:257–9.

    Google Scholar 

  21. 21

    Boettner EA, Wolter JR . Transmission of the ocular media. Invest Ophthalmol Vis Sci 1962;1:776–83.

    Google Scholar 

  22. 22

    Das T, Nirankari MS, Chaddah MR . Solar chorioretinal burn. Am J Ophthalmol 1956;41:1048–53.

    CAS  Article  Google Scholar 

  23. 23

    Berson D . Solar eclipse-findings among children. Metab Ophthalmol 1978;2:351–2.

    Google Scholar 

Download references

Author information



Corresponding author

Correspondence to M Michaelides.

Additional information

Presented as a poster at the Annual Congress of the Royal College of Ophthalmologists, 2000

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Michaelides, M., Rajendram, R., Marshall, J. et al. Eclipse retinopathy. Eye 15, 148–151 (2001).

Download citation


  • Eclipse blindness
  • Eclipse retinopathy
  • Macula
  • Photoretinitis
  • Retina
  • Solar eclipse
  • Solar retinopathy

Further reading


Quick links